Haemonetics (HAE) Gains from Investment Securities (2013 - 2022)

Haemonetics' (HAE) quarterly Gains from Investment Securities came in at -$504000.0 in Q3 2022, down 105.16% year-on-year from $9.8 million in Q3 2021, and down 366.67% quarter-over-quarter from $189000.0 in Q2 2022.

Haemonetics (HAE) Gains from Investment Securities (2013 - 2022) Analysis & Trends

Haemonetics' Gains from Investment Securities history runs 5 years deep, the most recent figure standing at -$504000.0 for Q3 2022.

  • On a quarterly basis, Gains from Investment Securities fell 105.16% year-over-year to -$504000.0 in Q3 2022; TTM through Apr 2023 was -$504000.0, a 104.82% decrease from a year earlier, with the FY2023 full-year figure at -$504000.0, down 104.82% from the prior year.
  • Gains from Investment Securities declined to -$504000.0 in Q3 2022 per HAE's latest filing, from $189000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $9.8 million in Q3 2021 and bottomed at -$504000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Haemonetics 3.78 Bn 3.54 Bn 198.21 Mn

Historic Data

Download Data
DateValue
Jul 2, 2022 -504,000.00
Jul 2, 2022 -504,000.00
Apr 2, 2022 189,000.00
Apr 2, 2022 189,000.00
Jan 1, 2022 927,000.00
Jan 1, 2022 927,000.00
Oct 2, 2021 -429,000.00
Oct 2, 2021 -429,000.00
Jul 3, 2021 9.77 Mn
Jul 3, 2021 9.77 Mn
Dec 26, 2015 -4.90 Mn
Dec 26, 2015 -4.90 Mn
Sep 26, 2015 88,000.00
Sep 26, 2015 88,000.00
Jun 27, 2015 83,000.00
Jun 27, 2015 83,000.00
Mar 28, 2015 -3.62 Mn
Mar 28, 2015 -3.62 Mn
Dec 27, 2014 246,000.00
Dec 27, 2014 246,000.00